The potential long-term neurological improvement of early hyperbaric oxygen therapy on hemorrhagic stroke in the diabetics.

What Researchers Did

Researchers conducted a randomised controlled trial involving 79 diabetic patients with acute intracerebral hemorrhage to compare early hyperbaric oxygen therapy with normobaric oxygen therapy.

What They Found

At six months, the hyperbaric oxygen therapy group showed significantly better neurological outcomes compared to the normobaric group, with 89.4% achieving a good outcome on the modified Rankin Scale versus 68.8% (P=0.045). Additionally, 80.9% in the hyperbaric group had good outcomes on the NIHSS compared to 56.2% in the normobaric group (P=0.035).

Canadian Relevance

This study does not have a direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.

Study Limitations

A limitation of this study is the relatively small sample size, which may affect the generalizability of the findings.